Literature DB >> 15846974

The gene of the complement-binding protein, an important anti-inflammatory factor of orthopoxviruses, is deleted from the genome of Western African strains of monkeypox virus.

E A Uvarova1, A V Totmenin, L S Sandakhchiev, S N Shchelkunov.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15846974     DOI: 10.1007/s10628-005-0021-y

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.834


× No keyword cloud information.
  12 in total

1.  Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense.

Authors:  S A Smith; N P Mullin; J Parkinson; S N Shchelkunov; A V Totmenin; V N Loparev; R Srisatjaluk; D N Reynolds; K L Keeling; D E Justus; P N Barlow; G J Kotwal
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins.

Authors:  G J Kotwal; B Moss
Journal:  Nature       Date:  1988-09-08       Impact factor: 49.962

3.  Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement.

Authors:  Ariella M Rosengard; Yu Liu; Zhiping Nie; Robert Jimenez
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

4.  The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein.

Authors:  C G Miller; S N Shchelkunov; G J Kotwal
Journal:  Virology       Date:  1997-03-03       Impact factor: 3.616

5.  Isolation and properties of the causal agent of a new variola-like disease (monkeypox) in man.

Authors:  S S Marennikova; E M Seluhina; N N Mal'ceva; K L Cimiskjan; G R Macevic
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

6.  Evidence for recent genetic variation in monkeypox viruses.

Authors:  N J Douglass; M Richardson; K R Dumbell
Journal:  J Gen Virol       Date:  1994-06       Impact factor: 3.891

7.  Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001.

Authors:  Hermann Meyer; Mathilde Perrichot; Markus Stemmler; Petra Emmerich; Herbert Schmitz; Francis Varaine; Robert Shungu; Florimond Tshioko; Pierre Formenty
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

8.  Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence.

Authors:  S N Isaacs; G J Kotwal; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

9.  Orthopoxvirus DNA: a comparison of restriction profiles and maps.

Authors:  J J Esposito; J C Knight
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

10.  Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997.

Authors:  Y J Hutin; R J Williams; P Malfait; R Pebody; V N Loparev; S L Ropp; M Rodriguez; J C Knight; F K Tshioko; A S Khan; M V Szczeniowski; J J Esposito
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883

View more
  1 in total

Review 1.  Poxviruses and the evolution of host range and virulence.

Authors:  Sherry L Haller; Chen Peng; Grant McFadden; Stefan Rothenburg
Journal:  Infect Genet Evol       Date:  2013-10-24       Impact factor: 3.342

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.